Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:20 PM
Ignite Modification Date:
2025-12-26 @ 10:20 PM
NCT ID:
NCT01963312
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of benign prostatic hyperplasia with moderate or severe obstructive lower urinary tract symptoms
* Refractory to medical treatment for at least 6 months
* Qmax (maximum urinary flow) less than 10 mL/second
Exclusion Criteria:
* Patients not candidates for transurethral resection of the prostate (TURP)
* Advanced atherosclerosis and tortuosity of the iliac arteries
* No visualization of the prostatic artery CT angiography study
* Urethral stenosis, detrusor failure or neurogenic bladder
* Glomerular filtration \< 30 mL/min
* Presence of malignant tumor
* History of allergy to iodinated contrast
* Patients with any other medical or social condition, deemed by the Investigator to be likely to interfere with a patient's ability to sign informed consent, cooperate and participate in the study, or interfere with the interpretation of the results
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
60 Years
Study:
NCT01963312
Study Brief:
Protocol Section:
NCT01963312